Atlas Trials

A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma

Clinical trial NCT04799548 · UNKNOWN

Trial details

NCT number
NCT04799548
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Gastric Cancer
Start date
2021-12-30
Primary completion
2024-12-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.